GD
AGN

Grandfield & Dodd’s Allergan plc AGN Stock Holding History

Grandfield & Dodd’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-930
Closed -$214K – 187
2016
Q3 		$214K Buy
+930
New +$227K 0.03% 172
2016
Q2 		– Sell
-780
Closed -$209K – 172
2016
Q1 		$209K Hold
780
– – 0.03% 164
2015
Q4 		$244K Hold
780
– – 0.04% 157
2015
Q3 		$212K Buy
+780
New +$240K 0.04% 164

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Grandfield & Dodd's AGN Position: Q4 2016 in Review

Grandfield & Dodd sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 930 shares — an estimated $214K sold.

Grandfield & Dodd first reported a position in AGN in Q3 2015 and held it in 4 quarters. The position peaked at $244K in Q4 2015. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Grandfield & Dodd reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Grandfield & Dodd sold 930 Allergan plc shares in Q4 2016, an estimated $214K.
  • Grandfield & Dodd first reported a position in Allergan plc in Q3 2015 and held it in 4 quarters.
  • Grandfield & Dodd's Allergan plc position peaked at $244K in Q4 2015.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Grandfield & Dodd's 13F filing for Q4 2016, filed 2 Feb 2017.